| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,012 | 0,020 | 15:00 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | Preveceutical Medical Inc: Preveceutical closes $455k second tranche of placement | 1 | Stockwatch | ||
| 20.10. | PreveCeutical Medical Inc.: PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc. | 227 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 13.10. | PreveCeutical Medical boosts private placement to $1.2M, following shareholder meeting approvals | 4 | Seeking Alpha | ||
| 11.10. | Preveceutical Medical Inc: Preveceutical hikes placement, releases AGSM results | 4 | Stockwatch | ||
| 10.10. | PreveCeutical Medical Inc.: PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement | 388 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all... ► Artikel lesen | |
| PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 20.09. | Preveceutical Medical Inc: Preveceutical mails documents for Oct. 10 AGM | 4 | Stockwatch | ||
| 20.09. | PreveCeutical Medical Inc.: PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics | 861 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its... ► Artikel lesen | |
| 06.09. | Preveceutical Medical Inc: Preveceutical closes $646,500 tranche one of placement | 4 | Stockwatch | ||
| 05.09. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 821 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 04.09. | PreveCeutical Medical Inc.: PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics | 437 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that it has entered... ► Artikel lesen | |
| 29.08. | Preveceutical Medical Inc: Preveceutical reschedules AGM to Oct. 10 | 2 | Stockwatch | ||
| 29.08. | PreveCeutical Medical Inc.: PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation | 563 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that, further to its News... ► Artikel lesen | |
| 20.08. | Preveceutical Medical Inc: Preveceutical's BioGene appoints chief tech officer | 1 | Stockwatch | ||
| 20.08. | PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer | 414 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that... ► Artikel lesen | |
| 19.08. | Preveceutical Medical Inc: Preveceutical's BioGene appoints research director | 1 | Stockwatch | ||
| 19.08. | PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research | 242 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that... ► Artikel lesen | |
| 05.08. | Preveceutical Medical Inc: Preveceutical further reschedules AGSM to Sept. 29 | 3 | Stockwatch | ||
| 09.07. | Preveceutical Medical Inc: Preveceutical Medical reschedules AGSM to Sept. 5 | 5 | Stockwatch | ||
| 09.07. | PreveCeutical Medical Inc.: PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting | 276 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News... ► Artikel lesen | |
| 01.07. | Preveceutical Medical Inc: Preveceutical appoints Tavares chief technology officer | 2 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,270 | +0,78 % | DAX leichter erwartet: Fresenius, BMW, Vonovia und Siemens Healthineers im Fokus | Die Korrektur dürfte sich fortsetzen: Die Kursverluste vor allem im US-Technologiesektor am Vorabend dürften den deutschen Aktienmarkt im heutigen Handel belasten. Der Broker IG taxierte den Leitindex... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,420 | -0,19 % | Börse am Morgen: FMC, Hugo Boss, Palantir, Telefonica, Gold Marktbericht | Trotz der mauen Konjunktur in Deutschland erwies sich der deutsche Mittelstand 2024 erneut als Jobmotor. Laut KfW-Mittelstandspanel stieg die Beschäftigungszahl in kleinen und mittleren Unternehmen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,080 | +1,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Siemens Healthineers von 61 auf 57 Euro gesenkt, die Einstufung jedoch auf "Buy" belassen. Er habe die Schätzungen an die Zielvorgaben... ► Artikel lesen | |
| DRAEGERWERK | 68,30 | -0,44 % | ANALYSE-FLASH: Jefferies hebt Ziel für Drägerwerk auf 73 Euro - 'Hold' | NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat das Kursziel für Drägerwerk von 67 auf 73 Euro angehoben und die Einstufung auf "Hold" belassen. Das Medizin- und Sicherheitstechnik-Unternehmen habe... ► Artikel lesen | |
| MEDTRONIC | 82,34 | -0,02 % | Medtronic: Empowering Employees To Lead Environmental Change | Together, we can make a positive impact on the environment through advocacy, education, and connection NORTHAMPTON, MA / ACCESS Newswire / November 11, 2025 / We're focused on building a more sustainable... ► Artikel lesen | |
| INTUITIVE SURGICAL | 497,40 | +0,72 % | Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know. | ||
| THERMO FISHER | 505,00 | -0,28 % | Thermo Fisher Gains 510(k) Clearance For EXENT System To Aid Multiple Myeloma Diagnosis | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) on Wednesday announced 510(k) clearance for its EXENT Analyzer and Immunoglobulin Isotypes (GAM) Assay, aimed at supporting faster... ► Artikel lesen | |
| TELADOC HEALTH | 6,553 | +0,34 % | Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit | ||
| SERNOVA BIOTHERAPEUTICS | 0,086 | -1,72 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| FAMICORD | 5,300 | -0,93 % | EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. erwirbt 100 % der Anteile an der Stammzellbank 'nOvum' spólka z ograniczona odpowiedzialnoscia, Warschau, Polen | EQS-Ad-hoc: FamiCord AG / Schlagwort(e): Fusionen & Übernahmen
FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. erwirbt 100 % der Anteile an der Stammzellbank 'nOvum' spólka z ograniczona... ► Artikel lesen | |
| CHARMING MEDICAL | 29,350 | +6,73 % | Charming Medical Limited Announces Closing of Initial Public Offering | HONG KONG, Oct. 22, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,340 | 0,00 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| GENEDX | 139,91 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 23,830 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen |